Research  >  About SRI  >  Scientist Profiles  >  Scientists M-R
Share:  
|
PAGE
MENU

Scientist profiles M-R

SRI Profiles

Ian Poon, MD, FRCPC

Affiliate scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room T2 134
Toronto, ON
M4N 3M5

Phone: 416-480-4951
Fax: 416-480-6002

Administrative Assistant: Debbie Posner
Phone: 416-480-4951
Email: debbie.posner@sunnybrook.ca

Education:

  • B.Sc., 1991, life sciences, Queen's University, Canada
  • MD, 1995, University of Ottawa, Canada
  • FRCPC, 2000, radiation oncology, University of Toronto, Canada

Appointments and Affiliations:

  • Affiliate scientist, Physical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute
  • Radiation oncologist, Odette Cancer Centre and Sunnybrook Health Sciences Centre
  • Stereotactic body radiotherapy program director, department of radiation oncology, Odette Cancer Centre
  • Lung site group leader
  • Assistant professor, department of radiation oncology, U of T

Research Foci:

  • Intra-treatment response monitoring using dynamic positron emission tomography imaging in head and neck cancer
  • Imaging pathological correlation in head and neck cancer
  • Intensity-modulated radiation therapy in head and neck cancer

Research Summary:

Dr. Poon is leading a multi-institutional study supported by the Ontario Institute of Cancer Research. The study seeks to individualize radiation treatment using intra-treatment, dynamic, fluorodeoxyglucose positron emission tomography (PET) scanning in advanced head and neck cancer. He is also leading a cross-discipline initiative to use 3-D reconstructed whole surgical specimens to correlate the gross tumour volume with pre-operative computed tomography, magnetic resonance imaging and PET in head and neck cancer as well as to define definitively the microscopic tumour volume.

Selected Publications:

See current publications list at PubMed.

  1. Brotherston D, Poon I, Le T, Leung M, Kiss A, Ringash J, Balogh J, Lee J, Wright JR. Patient preference for oropharyngeal cancer treatment de-escalation. Head Neck. 2013 Feb;35(2):151–9.
  2. Mohammed FF, Poon I, Zhang L, Elliot L, Hodson ID, Sagar SM, Wright J. Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer. Head Neck. 2012 Jul; 34(7):985–993. (Senior responsible author).
  3. Campbell SAM, Poon I, Markel D, Vena D, Higgins K, Enepekides D, Wong J, Allo G, Morgen E, Khaoum N, Smith B, Balogh J, MacKenzie R, Davidson J, Wang D, Yaffe M. Evaluation of microscopic disease in oral tongue cancer using whole mount histopathological techniques: implications for the management of head and neck cancers. Int J Radiat Oncol Biol Phys. 2012 Feb; 82(2):574–581. (Senior responsible author).
  4. Poon I, Fischbein N, Lee N, Akazawa P, Xia P, Quivey J, Phillips T. A population-based atlas and clinical target volume for the head and neck lymph nodes. Int J Radiat Oncol Biol Phys.2004 Aug; 59(5):1301–1311.

Related Links: